Fortress Biotech, Inc.

FBIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 1, 2026 8-K
4 Oct 1, 2026
SCHEDULE 13G Sep 1, 2026
10-Q Aug 13, 2026 10-Q
8-K Aug 13, 2026 8-K
4 Jun 24, 2026
8-K Jun 23, 2026 8-K
SCHEDULE 13G/A May 15, 2026
10-Q May 14, 2026 10-Q
8-K May 14, 2026 8-K
DEFA14A Apr 28, 2026 DEFA14A
DEF 14A Apr 28, 2026 DEF 14A
4 Apr 1, 2026
10-K Mar 31, 2026 10-K
8-K Mar 31, 2026 8-K
8-K Mar 30, 2026 8-K
SCHEDULE 13D/A Mar 20, 2026
4 Mar 20, 2026
4 Mar 20, 2026
8-K Feb 23, 2026 8-K
8-K Jan 13, 2026 8-K
SCHEDULE 13D/A Jan 6, 2026
4 Jan 6, 2026
SCHEDULE 13D/A Jan 5, 2026
4 Jan 5, 2026
← Newer Page 1 of 36 · 885 filings Older →